7 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease Indication ... be considered (doses ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
., concomitant medications ... injection) for 1–4 doses ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Achieve a total dose ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
Selection - Migraine Management ... month to avoid medication-overuse ... response: • Consider preventive ... • Try higher dose ... #pharmacology #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... adjusting the dose ... #differential #algorithm ... #management #cardiology ... icu #clinical #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... to Table 5 for dosing ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
months or • RFB (dose ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology